Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents

Abstract Background The carbazole skeleton is an important structural motif occurring naturally or synthesized chemically and has antihistaminic, antioxidant, antitumor, antimicrobial, and anti-inflammatory activities. Objectives This study aimed to design and synthesize a novel series of carbazole...

Full description

Bibliographic Details
Main Authors: İrfan Çapan, Mohammed Hawash, Nidal Jaradat, Yusuf Sert, Refik Servi, İrfan Koca
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Chemistry
Subjects:
Online Access:https://doi.org/10.1186/s13065-023-00961-y
_version_ 1797801571959963648
author İrfan Çapan
Mohammed Hawash
Nidal Jaradat
Yusuf Sert
Refik Servi
İrfan Koca
author_facet İrfan Çapan
Mohammed Hawash
Nidal Jaradat
Yusuf Sert
Refik Servi
İrfan Koca
author_sort İrfan Çapan
collection DOAJ
description Abstract Background The carbazole skeleton is an important structural motif occurring naturally or synthesized chemically and has antihistaminic, antioxidant, antitumor, antimicrobial, and anti-inflammatory activities. Objectives This study aimed to design and synthesize a novel series of carbazole derivatives and evaluate their antiproliferative and antioxidant activities. Methods The synthesized compounds were characterized utilizing HRMS, 1H-, and 13CAPT-NMR, and assessed for their anticancer, antifibrotic, and antioxidant effects utilizing reference biomedical procedures. In addition, the AutoDock Vina application was used to perform in-silico docking computations. Results A series of carbazole derivatives were synthesized and characterized in the current study. Compounds 10 and 11 were found to have a stronger antiproliferative effect than compounds 2–5 against HepG2, HeLa, and MCF7 cancer cell lines with IC50 values of 7.68, 10.09, and 6.44 µM, respectively. Moreover, compound 9 showed potent antiproliferative activity against HeLa cancer cell lines with an IC50 value of 7.59 µM. However, except for compound 5, all of the synthesized compounds showed moderate antiproliferative activities against CaCo-2 with IC50 values in the range of 43.7–187.23 µM. All of these values were compared with the positive control anticancer drug 5-Fluorouracil (5-FU). In addition, compound 9 showed the most potent anti-fibrotic compound, and the cellular viability of LX-2 was found 57.96% at 1 µM concentration in comparison with the positive control 5-FU. Moreover, 4 and 9 compounds showed potent antioxidant activities with IC50 values of 1.05 ± 0.77 and 5.15 ± 1.01 µM, respectively. Conclusion Most of the synthesized carbazole derivatives showed promising antiproliferative, antioxidant, and antifibrotic biological effects, and further in-vivo investigations are needed to approve or disapprove these results.
first_indexed 2024-03-13T04:52:49Z
format Article
id doaj.art-64dfe6ebb47e4b6bb6beeefb93b64da1
institution Directory Open Access Journal
issn 2661-801X
language English
last_indexed 2024-03-13T04:52:49Z
publishDate 2023-06-01
publisher BMC
record_format Article
series BMC Chemistry
spelling doaj.art-64dfe6ebb47e4b6bb6beeefb93b64da12023-06-18T11:05:29ZengBMCBMC Chemistry2661-801X2023-06-0117111710.1186/s13065-023-00961-yDesign, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agentsİrfan Çapan0Mohammed Hawash1Nidal Jaradat2Yusuf Sert3Refik Servi4İrfan Koca5Department of Material and Material Processing Technologies, Gazi University, Technical Sciences Vocational CollegeDepartment of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National UniversityDepartment of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National UniversityYozgat Bozok University, Sorgun Vocational SchoolDepartment of Anatomy, Faculty of Medicine, Firat UniversityDepartment of Chemistry, Faculty of Art & Sciences, Yozgat Bozok UniversityAbstract Background The carbazole skeleton is an important structural motif occurring naturally or synthesized chemically and has antihistaminic, antioxidant, antitumor, antimicrobial, and anti-inflammatory activities. Objectives This study aimed to design and synthesize a novel series of carbazole derivatives and evaluate their antiproliferative and antioxidant activities. Methods The synthesized compounds were characterized utilizing HRMS, 1H-, and 13CAPT-NMR, and assessed for their anticancer, antifibrotic, and antioxidant effects utilizing reference biomedical procedures. In addition, the AutoDock Vina application was used to perform in-silico docking computations. Results A series of carbazole derivatives were synthesized and characterized in the current study. Compounds 10 and 11 were found to have a stronger antiproliferative effect than compounds 2–5 against HepG2, HeLa, and MCF7 cancer cell lines with IC50 values of 7.68, 10.09, and 6.44 µM, respectively. Moreover, compound 9 showed potent antiproliferative activity against HeLa cancer cell lines with an IC50 value of 7.59 µM. However, except for compound 5, all of the synthesized compounds showed moderate antiproliferative activities against CaCo-2 with IC50 values in the range of 43.7–187.23 µM. All of these values were compared with the positive control anticancer drug 5-Fluorouracil (5-FU). In addition, compound 9 showed the most potent anti-fibrotic compound, and the cellular viability of LX-2 was found 57.96% at 1 µM concentration in comparison with the positive control 5-FU. Moreover, 4 and 9 compounds showed potent antioxidant activities with IC50 values of 1.05 ± 0.77 and 5.15 ± 1.01 µM, respectively. Conclusion Most of the synthesized carbazole derivatives showed promising antiproliferative, antioxidant, and antifibrotic biological effects, and further in-vivo investigations are needed to approve or disapprove these results.https://doi.org/10.1186/s13065-023-00961-yCarbazoleAnticancerAntifibroticLX-2AntioxidantDoxorubicin
spellingShingle İrfan Çapan
Mohammed Hawash
Nidal Jaradat
Yusuf Sert
Refik Servi
İrfan Koca
Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents
BMC Chemistry
Carbazole
Anticancer
Antifibrotic
LX-2
Antioxidant
Doxorubicin
title Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents
title_full Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents
title_fullStr Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents
title_full_unstemmed Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents
title_short Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents
title_sort design synthesis molecular docking and biological evaluation of new carbazole derivatives as anticancer and antioxidant agents
topic Carbazole
Anticancer
Antifibrotic
LX-2
Antioxidant
Doxorubicin
url https://doi.org/10.1186/s13065-023-00961-y
work_keys_str_mv AT irfancapan designsynthesismoleculardockingandbiologicalevaluationofnewcarbazolederivativesasanticancerandantioxidantagents
AT mohammedhawash designsynthesismoleculardockingandbiologicalevaluationofnewcarbazolederivativesasanticancerandantioxidantagents
AT nidaljaradat designsynthesismoleculardockingandbiologicalevaluationofnewcarbazolederivativesasanticancerandantioxidantagents
AT yusufsert designsynthesismoleculardockingandbiologicalevaluationofnewcarbazolederivativesasanticancerandantioxidantagents
AT refikservi designsynthesismoleculardockingandbiologicalevaluationofnewcarbazolederivativesasanticancerandantioxidantagents
AT irfankoca designsynthesismoleculardockingandbiologicalevaluationofnewcarbazolederivativesasanticancerandantioxidantagents